BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8862105)

  • 41. Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients.
    Dick JD; Shull V; Karp JE; Valentine J
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S47-54. PubMed ID: 3127218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence and molecular epidemiology of Pseudomonas aeruginosa bacteremias in patients with acute leukemia: analysis by pulsed-field gel electrophoresis.
    Fanci R; Paci C; Anichini P; Pecile P; Marra G; Casini C; Nicoletti P
    New Microbiol; 2003 Oct; 26(4):353-61. PubMed ID: 14596346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Surgical bacteremia. Analysis of 210 episodes with special attention to factors influencing prognosis].
    Maradona JA; Alvarez MA; Cartón JA; Arribas JM
    Enferm Infecc Microbiol Clin; 1992 Jan; 10(1):4-10. PubMed ID: 1498174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [138 episodes of bacteremia or fungemia in patients with solid organ (renal or hepatic) transplantation].
    Moreno A; Mensa J; Almela M; Vilardell J; Navasa M; Claramonte J; Cruceta A; Serrano R; García-Valdecasas JC; Soriano E
    Med Clin (Barc); 1994 Jul; 103(5):161-4. PubMed ID: 7934276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance of and outcomes for Bacteroides fragilis bacteremia.
    Cheng CW; Lin HS; Ye JJ; Yang CC; Chiang PC; Wu TS; Lee MH
    J Microbiol Immunol Infect; 2009 Jun; 42(3):243-50. PubMed ID: 19812858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study.
    Vuotto F; Berthon C; Lemaitre N; Duhamel A; Balkaran S; Le Ray E; Micol JB; Faure K; Alfandari S
    Am J Infect Control; 2013 Jun; 41(6):527-30. PubMed ID: 23219670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical approach to infection in patients with hematologic malignancy].
    Funada H
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):178-83. PubMed ID: 1371045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1.
    Vidal F; Mensa J; Martínez JA; Almela M; Marco F; Gatell JM; Richart C; Soriano E; Jiménez de Anta MT
    Eur J Clin Microbiol Infect Dis; 1999 Jul; 18(7):473-7. PubMed ID: 10482023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia.
    Bates DW; Pruess KE; Lee TH
    Arch Intern Med; 1995 Mar; 155(6):593-8. PubMed ID: 7887754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.
    Todeschini G; Franchini M; Tecchio C; Meneghini V; Pizzolo G; Veneri D; Murari C; Ricetti MM; Perona G
    Int J Infect Dis; 1998-1999 Winter; 3(2):99-104. PubMed ID: 10225988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bacteremia secondary to decubitus ulcer].
    Espejo Arenas E; Bella Cueto F; Aloy Duch A; Morera Pomarede MA; Espaulella Panicot J; Mauri Pont M
    Med Clin (Barc); 1989 Nov; 93(16):604-6. PubMed ID: 2615535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Enterococcus faecalis bacteremia].
    Gómez J; Baños V; Sempere M; Ruiz J; Cano A; Canteras M; Apellániz G; Valdés M
    Med Clin (Barc); 1991 Jun; 97(4):133-6. PubMed ID: 1910132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A model to predict mortality following Pseudomonas aeruginosa bacteremia.
    Hirsch EB; Cottreau JM; Chang KT; Caeiro JP; Johnson ML; Tam VH
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):97-102. PubMed ID: 22056006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Projected impact of monoclonal anti-endotoxin antibody therapy.
    Bates DW; Lee TH
    Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy.
    Siegman-Igra Y; Ravona R; Primerman H; Giladi M
    Int J Infect Dis; 1998; 2(4):211-5. PubMed ID: 9763504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Primary cutaneous cryptococcosis and bacterial pneumonia caused by Pseudomonas aeruginosa in AIDS: clinical case and review of the literature].
    Dronda F; González-López A; Fernández-Martín JI; Alonso-Sanz M; Chaves F; López-Cubero L
    Enferm Infecc Microbiol Clin; 1996 Feb; 14(2):101-5. PubMed ID: 8714157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined pre-immunization and granulocyte transfusion therapy for treatment of pseudomonas septicemia in neutropenic dogs.
    Harvath L; Andersen BR; Zander AR; Epstein RB
    J Lab Clin Med; 1976 May; 87(5):840-7. PubMed ID: 1270891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and risk factors of recurrent episodes of bacteremia in adults.
    Capdevila JA; Almirante B; Pahissa A; Planes AM; Ribera E; Martínez-Vázquez JM
    Arch Intern Med; 1994 Feb; 154(4):411-5. PubMed ID: 8117173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bacterial septicemia in neutropenia patients].
    Vernant JP; Thibault M; Cordonnier C; Feghali W; Brun B; Dreyfus B; Duval J; Rochant H
    Ann Med Interne (Paris); 1983; 134(7):629-35. PubMed ID: 6666900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical analysis of Pseudomonas aeruginosa bacteremia].
    Kumasaka K; Hosokawa N; Yanai M; Yagoshi M; Simoguchi K; Kawano K
    Rinsho Byori; 1999 Nov; 47(11):1064-9. PubMed ID: 10590685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.